Piramal Pharma Limited Piramal Pharma Limited

Piramal Pharma Limited

PPLPHARMA

Rank in Stocks #4213
Piramal Pharma Limited operates as a pharmaceutical company in the United... Piramal Pharma Limited operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network. It also operates contract development and manufacturing organization that provides services across the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; offers inhalation anesthetics, intrathecal therapy, injectable pain and anesthesia drugs, and other generic and specialty products; and analgesics, skin care, vitamin/mineral supplement, kids’ wellness, digestives, women’s health, and hygiene, as well as adult incontinence. The company was incorporated in 2020 and is based in Mumbai, India.
Share Price
$2.60
Last synced: 2026-11-13
Market Cap
$3.44B
Change (1 day)
-0.59%
Change (1 year)
21.88%
Country

Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this

Trade Piramal Pharma Limited (PPLPHARMA)

Category

Healthcare
EPS for Piramal Pharma Limited (PPLPHARMA)
EPS as of September 2026 TTM: $-0.02
According to Piramal Pharma Limited's latest financial reports, its current EPS (TTM) is $-0.02. At the end of 2025 the company had an EPS of $0.01, an increase over its 2024 EPS of 0.00.
EPS history for Piramal Pharma Limited from 2021 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-0.02 -268.00%
2025 $0.01 376.47%
2024 0.00 -109.09%
2023 $-0.02 -145.95%
2022 $0.04 -36.60%
2021 $0.06 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$6.03 -35,992.26%
DE
$6.01 -35,860.71%
DE
$1.53 -9,224.40%
JP
$3.66 -21,885.71%
CH
$0.45 -2,778.57%
IL

Questions about Piramal Pharma Limited's earnings per share (EPS)

What is Piramal Pharma Limited's earnings per share (EPS)?

Piramal Pharma Limited's earnings per share (EPS) over the last twelve months is $-0.02, as of Sep 2026.

What was Piramal Pharma Limited's earnings per share (EPS) in 2025?

In 2025, Piramal Pharma Limited's earnings per share (EPS) was $0.01, compared with 0.00 in 2024.

How has Piramal Pharma Limited's earnings per share (EPS) changed since 2021?

From 2021 to 2025, Piramal Pharma Limited's earnings per share (EPS) went from $0.06 to $0.01, an average decline of 36.11% a year.

How does Piramal Pharma Limited's earnings per share (EPS) compare with similar companies?

Piramal Pharma Limited's earnings per share (EPS) ($-0.02) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.03.